Savara

$1.95
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.09 (-4.41%) Today

$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell Savara and other stocks, options, and ETFs commission-free!

About SVRA

Savara Inc. Common Stock, also called Savara, is a clinical-stage pharmaceutical company, which engages in the development and commercialization of novel therapies for the treatment of serious or life-threatening rare respiratory diseases.

CEO

Matthew Pauls

Employees

Headquarters

Austin, Texas

Founded

2017

Market Cap

219.98M

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

4.15M

High Today

$2.01

Low Today

$1.91

Open Price

$2.00

Volume

1.31M

52 Week High

$3.58

52 Week Low

$0.9952

SVRA Earnings

-$0.41

-$0.27

-$0.14

$0.00

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Q1 FY21

Estimated

— per share

Actual

Expected May 6